Pre-order Enquiry
Request Free Sample
Global Amyotrophic Lateral Sclerosis Drugs Market Size, Status and Forecast 2019-2025
SKU ID : QYR-14343293 | Publishing Date : 18-Jun-2019 | No. of pages : 99
Detailed TOC of Global Amyotrophic Lateral Sclerosis Drugs Market Size, Status and Forecast 2019-2025
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Riluzole
1.4.3 Edaravone (Radicava)
1.4.4 CoQ10
1.4.5 Butylphthalide
1.4.6 Others
1.5 Market by Application
1.5.1 Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Amyotrophic Lateral Sclerosis Drugs Market Size
2.2 Amyotrophic Lateral Sclerosis Drugs Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis Drugs Market Size by Regions (2014-2025)
2.2.2 Amyotrophic Lateral Sclerosis Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Amyotrophic Lateral Sclerosis Drugs Market Size by by Players
3.1.1 Global Amyotrophic Lateral Sclerosis Drugs Revenue by by Players (2014-2019)
3.1.2 Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Amyotrophic Lateral Sclerosis Drugs Key Players Head office and Area Served
3.3 Key Players Amyotrophic Lateral Sclerosis Drugs Product/Solution/Service
3.4 Date of Enter into Amyotrophic Lateral Sclerosis Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2014-2019)
4.2 Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Amyotrophic Lateral Sclerosis Drugs Market Size (2014-2019)
5.2 Amyotrophic Lateral Sclerosis Drugs Key Players in United States
5.3 United States Amyotrophic Lateral Sclerosis Drugs Market Size by Type
5.4 United States Amyotrophic Lateral Sclerosis Drugs Market Size by Application
6 Europe
6.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size (2014-2019)
6.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Europe
6.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type
6.4 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application
7 China
7.1 China Amyotrophic Lateral Sclerosis Drugs Market Size (2014-2019)
7.2 Amyotrophic Lateral Sclerosis Drugs Key Players in China
7.3 China Amyotrophic Lateral Sclerosis Drugs Market Size by Type
7.4 China Amyotrophic Lateral Sclerosis Drugs Market Size by Application
8 Japan
8.1 Japan Amyotrophic Lateral Sclerosis Drugs Market Size (2014-2019)
8.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Japan
8.3 Japan Amyotrophic Lateral Sclerosis Drugs Market Size by Type
8.4 Japan Amyotrophic Lateral Sclerosis Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size (2014-2019)
9.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Southeast Asia
9.3 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Type
9.4 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Application
10 India
10.1 India Amyotrophic Lateral Sclerosis Drugs Market Size (2014-2019)
10.2 Amyotrophic Lateral Sclerosis Drugs Key Players in India
10.3 India Amyotrophic Lateral Sclerosis Drugs Market Size by Type
10.4 India Amyotrophic Lateral Sclerosis Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size (2014-2019)
11.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Central & South America
11.3 Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size by Type
11.4 Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size by Application
12 International Players Profiles
12.1 Sanofi
12.1.1 Sanofi Company Details
12.1.2 Company Description and Business Overview
12.1.3 Amyotrophic Lateral Sclerosis Drugs Introduction
12.1.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
12.1.5 Sanofi Recent Development
12.2 Mitsubishi Tanabe Pharma
12.2.1 Mitsubishi Tanabe Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Amyotrophic Lateral Sclerosis Drugs Introduction
12.2.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
12.2.5 Mitsubishi Tanabe Pharma Recent Development
12.3 Mylan
12.3.1 Mylan Company Details
12.3.2 Company Description and Business Overview
12.3.3 Amyotrophic Lateral Sclerosis Drugs Introduction
12.3.4 Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
12.3.5 Mylan Recent Development
12.4 Apotex
12.4.1 Apotex Company Details
12.4.2 Company Description and Business Overview
12.4.3 Amyotrophic Lateral Sclerosis Drugs Introduction
12.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
12.4.5 Apotex Recent Development
12.5 Glemark Generics
12.5.1 Glemark Generics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Amyotrophic Lateral Sclerosis Drugs Introduction
12.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
12.5.5 Glemark Generics Recent Development
12.6 Sun Pharma
12.6.1 Sun Pharma Company Details
12.6.2 Company Description and Business Overview
12.6.3 Amyotrophic Lateral Sclerosis Drugs Introduction
12.6.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
12.6.5 Sun Pharma Recent Development
12.7 Covis Pharma
12.7.1 Covis Pharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Amyotrophic Lateral Sclerosis Drugs Introduction
12.7.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
12.7.5 Covis Pharma Recent Development
12.8 Lunan Pharma
12.8.1 Lunan Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Amyotrophic Lateral Sclerosis Drugs Introduction
12.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
12.8.5 Lunan Pharma Recent Development
12.9 CSPC Pharmaceutical
12.9.1 CSPC Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Amyotrophic Lateral Sclerosis Drugs Introduction
12.9.4 CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
12.9.5 CSPC Pharmaceutical Recent Development
12.10 Ascend Laboratories
12.10.1 Ascend Laboratories Company Details
12.10.2 Company Description and Business Overview
12.10.3 Amyotrophic Lateral Sclerosis Drugs Introduction
12.10.4 Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
12.10.5 Ascend Laboratories Recent Development
12.11 EISAI
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Amyotrophic Lateral Sclerosis Drugs Market Size, Status and Forecast 2019-2025
List of Tables and FiguresTable Amyotrophic Lateral Sclerosis Drugs Key Market Segments
Table Key Players Amyotrophic Lateral Sclerosis Drugs Covered
Table Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type 2019-2025 (Million US$)
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Share by Type in 2018 & 2025
Figure Riluzole Figures
Table Key Players of Riluzole
Figure Edaravone (Radicava) Figures
Table Key Players of Edaravone (Radicava)
Figure CoQ10 Figures
Table Key Players of CoQ10
Figure Butylphthalide Figures
Table Key Players of Butylphthalide
Figure Others Figures
Table Key Players of Others
Table Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application in 2018 & 2025
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Amyotrophic Lateral Sclerosis Drugs Report Years Considered
Table Global Amyotrophic Lateral Sclerosis Drugs Market Size 2014-2025 (Million US$)
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Amyotrophic Lateral Sclerosis Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Amyotrophic Lateral Sclerosis Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Amyotrophic Lateral Sclerosis Drugs Market Share by Regions 2014-2019
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Share by Regions 2014-2019
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Share by Regions 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Amyotrophic Lateral Sclerosis Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Amyotrophic Lateral Sclerosis Drugs Market Share by by Players (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Share by by Players in 2018
Table Global Amyotrophic Lateral Sclerosis Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Amyotrophic Lateral Sclerosis Drugs Product/Solution/Service
Table Date of Enter into Amyotrophic Lateral Sclerosis Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Amyotrophic Lateral Sclerosis Drugs Market Size Share by Type (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2014-2019)
Table Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Amyotrophic Lateral Sclerosis Drugs Market Size Share by Application (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2014-2019)
Figure Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Application in 2018
Figure United States Amyotrophic Lateral Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Amyotrophic Lateral Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Amyotrophic Lateral Sclerosis Drugs Market Share (2018-2019)
Table United States Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2014-2019)
Table United States Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2014-2019)
Figure Europe Amyotrophic Lateral Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Amyotrophic Lateral Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Amyotrophic Lateral Sclerosis Drugs Market Share (2018-2019)
Table Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2014-2019)
Table Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2014-2019)
Figure China Amyotrophic Lateral Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Amyotrophic Lateral Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Amyotrophic Lateral Sclerosis Drugs Market Share (2018-2019)
Table China Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table China Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2014-2019)
Table China Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table China Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2014-2019)
Figure Japan Amyotrophic Lateral Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Amyotrophic Lateral Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Amyotrophic Lateral Sclerosis Drugs Market Share (2018-2019)
Table Japan Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2014-2019)
Table Japan Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Amyotrophic Lateral Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Amyotrophic Lateral Sclerosis Drugs Market Share (2018-2019)
Table Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2014-2019)
Table Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2014-2019)
Figure India Amyotrophic Lateral Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Amyotrophic Lateral Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Amyotrophic Lateral Sclerosis Drugs Market Share (2018-2019)
Table India Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table India Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2014-2019)
Table India Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table India Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2014-2019)
Figure Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Amyotrophic Lateral Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Amyotrophic Lateral Sclerosis Drugs Market Share (2018-2019)
Table Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2014-2019)
Table Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2014-2019)
Table Sanofi Company Details
Table Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019) (Million US$)
Figure Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
Table Sanofi Recent Development
Table Mitsubishi Tanabe Pharma Company Details
Table Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
Table Mitsubishi Tanabe Pharma Recent Development
Table Mylan Company Details
Table Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
Table Mylan Recent Development
Table Apotex Company Details
Table Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
Table Apotex Recent Development
Table Glemark Generics Company Details
Table Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
Table Glemark Generics Recent Development
Table Sun Pharma Company Details
Table Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
Table Sun Pharma Recent Development
Table Covis Pharma Company Details
Table Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
Table Covis Pharma Recent Development
Table Lunan Pharma Company Details
Table Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
Table Lunan Pharma Recent Development
Table CSPC Pharmaceutical Company Details
Table CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)(Million US$)
Figure CSPC Pharmaceutical Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
Table CSPC Pharmaceutical Recent Development
Table Ascend Laboratories Company Details
Table Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Ascend Laboratories Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2014-2019)
Table Ascend Laboratories Recent Development
Table EISAI Company Details
Table Global Amyotrophic Lateral Sclerosis Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Size Share by Regions (2019-2025)
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Size Share by Regions in 2025
Figure United States Amyotrophic Lateral Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Amyotrophic Lateral Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Amyotrophic Lateral Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Amyotrophic Lateral Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Amyotrophic Lateral Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Amyotrophic Lateral Sclerosis Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Size by Product (2019-2025)
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Size by Product in 2025
Table Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2025)
Figure Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global Amyotrophic Lateral Sclerosis Drugs Market Size, Status and Forecast 2019-2025
SanofiMitsubishi Tanabe Pharma
Mylan
Apotex
Glemark Generics
Sun Pharma
Covis Pharma
Lunan Pharma
CSPC Pharmaceutical
Ascend Laboratories
EISAI
Request Sample
Request Discount
